RE: GSA Capital18 Apr 2024 11:48
Bfd, its not that I think AVCt will be taken private but simply highlight that it could happen to refute the "Its all about the science and the science works, so we will have to be patient but it will all be ok, so just keep using these low prices to top up" brigade.
If the trial is delayed or has any sort of set back which costs time and the there is more money needed, then given the costs of listing (which are pretty high I believe), then an option would be to de-list and go private ala SuperDry at the moment.
As I say I don't think this is the most likely outcome but it is not beyond the realms. That was/is my point.
Its not about the science its all about the money.
I have no idea of the calibre of the staff of AVCT, other to say this BB was full of the same type of things when JV's were being discussed and new staff were being recruited for the LFT.
And that whether people like it or not this is a red flag for me. I hope this will be different but it is following the same path as the LFT inasmuch, best in the world, everything going great, deals being inked etc etc. but delay after delay kept occurring. and money being raised
Now we have a paradigm shift in this tech, everything going great, small deals being turned down etc etc, but with delay after delay and money being raised.
My default position is we don't actually know anything about what's going on either in the trial or the actual company. All we have is what has actually happened before as a reference. Does not mean history will repeat itself, but common sense should at least surface to be aware that this is a very high risk company that has a very poor track record to date about commercialising their tech.
So when I read chomp chomp, buy now, top here there and everywhere, I think it prudent to remind people of what we actually know as opposed to what we guess/hope is going on.